Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Feb;47(2):199-207.
doi: 10.1097/MLR.0b013e31818475b7.

Changes over time and disparities in schizophrenia treatment quality

Alisa B Busch  1 , Anthony F Lehman, Howard Goldman, Richard G Frank
Affiliations

Changes over time and disparities in schizophrenia treatment quality

Alisa B Busch et al. Med Care. 2009 Feb.

Abstract

Background: Schizophrenia medication and psychosocial treatment options have expanded since the Schizophrenia PORT was conducted. However, there also have been considerable changes in the delivery of mental health care in the public sector, as well as increasing state concerns about Medicaid cost containment.

Objectives: To examine trends and patient characteristics associated with differences in schizophrenia medication and visit treatment quality in a Medicaid population.

Research design: Observational study of claims data from July 1, 1996 to June 30, 2001.

Subjects: Florida Medicaid enrollees diagnosed with schizophrenia (N = 23,619).

Measures: We examined the likelihood of meeting any 1 and all 4 of the following quality standards: (1) receiving antipsychotic medication, (2) antipsychotic continuity, (3) dosing consistent with PORT recommendations, and (4) mental health visit continuity. Separate models were fit for acute and maintenance phases of treatment.

Results: Approximately 18% of acute and 7% of maintenance phases met all 4 quality standards. Antipsychotic quality improved (largely driven by an increasingly likelihood of receiving any antipsychotic), while visit continuity declined. The greatest disparities were seen for persons with co-occurring substance use disorders and of black race. Quality differences were often phase specific and at times in opposite directions across treatment phases.

Conclusions: The improvement in antipsychotic treatment quality is encouraging. However, visit continuity declined. This study highlights the importance of quality measurement that includes focus on different treatment modalities and phases of care, as well as for potentially vulnerable populations (such as persons with co-occurring substance use disorders and racial/ethnic minorities).

PubMed Disclaimer

References

    1. Lehman AF, Steinwachs DM, the Co-Investigators of the PORT Project Translating research into practice: The Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophrenia Bulletin. 1998;24(1):1–10. - PubMed
    1. Lehman AF, Steinwachs D, the Survey Co-Investigators of the PORT Project Patterns of usual care for schizophrenia: Initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey. Schizophrenia Bulletin. 1998;24(1):11–20. - PubMed
    1. Becker MA, Young MS, Ochshorn E, Diamond RJ. The relationship of antipsychotic medication class and adherence with treatment outcomes and costs for Florida Medicaid beneficiaries with schizophrenia. Administration, Policy and Mental Health and Mental Heatlh Services Research. 2007;34:307–314. - PubMed
    1. Gilmer TP, Dolder CR, Lacro JP, et al. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schozophrenia. American Journal of Psychiatry. 2004;161(4):692–699. - PubMed
    1. Walkup J, Wei W, Sambamoorthi U, Crystal S, Yanos PT. Provision of psychotherapy for a statewide population of Medicaid beneficiaries with schizophrenia. Psychological Services. 2006;3(4):227–238.

Publication types

MeSH terms

Substances